Cargando…

Correction: Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review

Detalles Bibliográficos
Autores principales:	Bozinoff, Nikki, Tardelli, Vitor Soares, Rubin-Kahana, Dafna Sara, Le Foll, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641772/ https://www.ncbi.nlm.nih.gov/pubmed/36345009 http://dx.doi.org/10.1186/s12954-022-00705-6

Ejemplares similares

Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review
por: Bozinoff, Nikki, et al.
Publicado: (2022)

Correction to: Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
por: Mezaache, Salim, et al.
Publicado: (2021)

Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper
por: Bozinoff, Nikki, et al.
Publicado: (2022)

Medical Cannabis and Past-Year Cannabis Use Disorder Among Adult Recreational Users in the United States: Results From a Nationally Representative Sample
por: Rubin-Kahana, Dafna Sara, et al.
Publicado: (2022)

The impact of cannabis legalization for recreational purposes on youth: A narrative review of the Canadian experience
por: Rubin-Kahana, Dafna Sara, et al.
Publicado: (2022)

Multiple Substance Use Disorders and Self-Reported Cognitive Function in U.S. Adults: Associations and Sex-Differences in a Nationally Representative Sample
por: Bourgault, Zoe, et al.
Publicado: (2022)

Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia
por: Larance, Briony, et al.
Publicado: (2020)

Neurochemical Alterations in Social Anxiety Disorder (SAD): A Systematic Review of Proton Magnetic Resonance Spectroscopic Studies
por: Elsaid, Sonja, et al.
Publicado: (2022)

Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
por: Mezaache, Salim, et al.
Publicado: (2021)

Facilitators of and barriers to buprenorphine initiation for people with opioid use disorder in the emergency department: protocol for a scoping review
por: Bozinoff, Nikki, et al.
Publicado: (2021)

The Insula: A Brain Stimulation Target for the Treatment of Addiction
por: Ibrahim, Christine, et al.
Publicado: (2019)

Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population‐based propensity‐score matched cohort study
por: Gomes, Tara, et al.
Publicado: (2022)

Extended-release monthly buprenorphine injection
por: Cuperfain, Ari B., et al.
Publicado: (2023)

Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
por: Zhao, Bin, et al.
Publicado: (2019)

Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco
por: Carter, Jamie, et al.
Publicado: (2019)

Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [(11)C]-(+)-PHNO study
por: Chukwueke, Chidera C., et al.
Publicado: (2021)

Correction: Adverse Events Reported From Hyaluronic Acid Dermal Filler Injections to the Facial Region: A Systematic Review and Meta-Analysis
por: Colon, Jessica, et al.
Publicado: (2023)

Correction to: Running on a high: parkrun and personal well-being
por: Grunseit, Anne, et al.
Publicado: (2019)

Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk
por: Tardelli, Vitor, et al.
Publicado: (2023)

Correction to: Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits
por: Askar, Raad, et al.
Publicado: (2021)

Correction: Preventive Pharmacovigilance: timely and precise prevention of adverse events through person-level patient screening and dose-level product surveillance
por: Yu, Yihua Bruce, et al.
Publicado: (2023)

Who Are the Regulars ?
Publicado: (1850)

Severe alcohol use disorder after initiation of selective serotonin reuptake inhibitor therapy
por: Gandhi, Preet, et al.
Publicado: (2023)

Pharmacokinetics of buprenorphine in pregnant sheep after intravenous injection
por: Hakomäki, Henriikka, et al.
Publicado: (2021)

Injection mensuelle de buprénorphine à libération prolongée
por: Cuperfain, Ari B., et al.
Publicado: (2023)

Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy
por: Truong, Van Thi Thanh, et al.
Publicado: (2023)

Transition from First Drug Use to Regular Injection among People Who Inject Drugs in Iran
por: Koozegar, Masoomeh, et al.
Publicado: (2018)

Correction: Rates of infectious keratitis and other ocular surface adverse events in corneal cross-linking for keratoconus and corneal ectasias performed in an office-based setting: a retrospective cohort study
por: Hafezi, Farhad, et al.
Publicado: (2023)

Correction: Frequency of Adverse Events after Vaccination with Different Vaccinia Strains
por: Kretzschmar, Mirjam, et al.
Publicado: (2006)

Personalized Care in Opioid Use Disorder maintained on Buprenorphine
por: Elarabi, H., et al.
Publicado: (2022)

Crushed and Injected Buprenorphine Tablets: Characteristics of Princeps and Generic Solutions
por: Bouquié, Régis, et al.
Publicado: (2014)

Buprenorphine
por: Mazurek, Jaroslaw, et al.
Publicado: (2014)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Correction: Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study
por: Rwema, Jean Olivier Twahirwa, et al.
Publicado: (2022)

Association between regular exercise and the risk of major adverse cardiovascular events in patients with pacemaker
por: Lee, S R, et al.
Publicado: (2023)

Correction: Adverse Events of Anti-Tumor Necrosis Factor α Therapy in Ankylosing Spondylitis
por: Tong, Qiang, et al.
Publicado: (2015)

Correction: T follicular helper cells: linking cancer immunotherapy and immune-related adverse events
Publicado: (2021)

Correction: Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study
Publicado: (2019)

Recurrent Endocarditis in Persons Who Inject Drugs
por: Rodger, Laura, et al.
Publicado: (2019)

Brucella Endocarditis in Persons Who Inject Drugs
por: Cafardi, John M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l3ev8c71k45hq0a7kkjiulbmvv